Stereotaxis launches V-Sono module for Vdrive Remote Navigation System

NewsGuard 100/100 Score

Stereotaxis, Inc. (NASDAQ:   STXS) today announced that the Company has released to the European market the V-Sono™ intracardiac echocardiography manipulator module for the Vdrive™ Remote Navigation System.

Designed to manipulate accessory devices such as variable loop catheters, steerable sheaths, and ultrasound catheters, the Vdrive™ platform combines magnetic navigation with the Odyssey™ information management system to bring precise control during catheter-based EP procedures.

The Company also announced the first human case using the V-Sono™ module has been performed by Dr. Georg Nolker of Herz und Diabeteszentrum Klinik fur Kardiologie in Bad Oeynhausen, Germany on April 30, 2012.  A patient was treated for a complex left persistent atrial fibrillation and Dr. Nolker performed a fully remote intervention, using the Vdrive Duo™ platform (the V-Loop™ module for the circular mapping catheter and the V-Sono™ module for the ICE catheter) in concert with the Niobe® ES Magnetic Navigation System.

Dr. Nolker said, "Intracardiac Echo has been long established to provide patient safety and cardiac visualization without radiation. This new robotic control makes intracardiac echo more stable, precise, and easier to use in a way that has not been previously available."      

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New cryoablation technique eliminates ventricular tachycardia in 94% of patients